Falconer, excellent commentary. You and I are very much coming from the same perspective on this company and its future potential. With early stage biotech investing, one is placing a bet on the concept and the management. The size of the bet can then be increased or decreased as the story unfolds. The concept here is excellent and holds huge potential. And so far, I have no reason to doubt or mistrust the capability of management.
I also have a small position and have plenty of time to increase it (with less risk) if the science and neurophysiological concepts are proven by the empirical data. At this point I am optimistic and continuing to monitor.
BTW, throughout my educational journey, some of my favorite teachers were those who taught biology/physiology (it was not arcane to me---smile). Congratulations on what I surmise was a rewarding career.